These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38956496)

  • 1. SerpinB2 deficiency is associated with delayed mammary tumor development and decreased pro-tumorigenic macrophage polarization.
    Piao YJ; Kim HS; Kim H; Shen J; Moon WK
    BMC Cancer; 2024 Jul; 24(1):792. PubMed ID: 38956496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression.
    Piao YJ; Kim HS; Han W; Moon WK
    BMC Genomics; 2022 Jun; 23(1):479. PubMed ID: 35768767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model.
    Oghumu S; Varikuti S; Terrazas C; Kotov D; Nasser MW; Powell CA; Ganju RK; Satoskar AR
    Immunology; 2014 Sep; 143(1):109-19. PubMed ID: 24679047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
    Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 modulates mammary tumor progression in response to collagen density.
    Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
    Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis.
    Schreiber C; Gruber A; Roßwag S; Saraswati S; Harkins S; Thiele W; Foroushani ZH; Munding N; Schmaus A; Rothley M; Dimmler A; Tanaka M; Garvalov BK; Sleeman JP
    Cancer Lett; 2022 May; 533():215600. PubMed ID: 35181478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphenol A Promotes the Invasive and Metastatic Potential of Ductal Carcinoma In Situ and Protumorigenic Polarization of Macrophages.
    Kim H; Kim HS; Piao YJ; Moon WK
    Toxicol Sci; 2019 Aug; 170(2):283-295. PubMed ID: 31143956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
    Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W
    Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model.
    McDonald SJ; Cranford TL; VanderVeen BN; Cardaci TD; Velázquez KT; Enos RT; Chatzistamou I; Fan D; Murphy EA
    Physiol Genomics; 2022 Nov; 54(11):433-442. PubMed ID: 36121133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
    Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
    Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
    Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
    Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages.
    Schroder WA; Hirata TD; Le TT; Gardner J; Boyle GM; Ellis J; Nakayama E; Pathirana D; Nakaya HI; Suhrbier A
    Sci Rep; 2019 Aug; 9(1):12421. PubMed ID: 31455834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    Rumney RMH; Coffelt SB; Neale TA; Dhayade S; Tozer GM; Miller G
    PLoS One; 2017; 12(12):e0188591. PubMed ID: 29220404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
    Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
    BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.